(3S,4S) -Tofacitinib
(3S,4S) -Tofacitinib is the less active S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.
Product Specifications
CAS Number
[1092578-47-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/_3S,4S_-Tofacitinib.html
Purity
99.75
Solubility
DMSO : ≥ 100 mg/mL|H2O : < 0.1 mg/mL
Smiles
CN(C1=NC=NC2=C1C=CN2)[C@H]3[C@@H](C)CCN(C(CC#N)=O)C3
Molecular Formula
C16H20N6O
Molecular Weight
312.37
Precautions
H302, H315, H319, H335
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2074076-01 0.1 mL
PE-Linked Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 5 (PCSK5)
Sign In for Pricing
View Details 
MBS2074076-02 0.2 mL
PE-Linked Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 5 (PCSK5)
Sign In for Pricing
View Details MBS2074076-03 0.5 mL
PE-Linked Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 5 (PCSK5)
Sign In for Pricing
View Details